Briefs

BSX Settles Another Mesh Lawsuit

Boston Scientific has settled another lawsuit involving allegations that its Pinnacle transvaginal mesh product harmed a patient while using it. The confidential settlement, reached May 11 in a U.S. district court in California would have gone to trial this week—the sixth against Boston Scientific over the device. The Marlborough, Mass., devicemaker, which is facing more than 26,000 liability lawsuits claiming the urinary incontinence device is defective and causes complications, plans to pay an estimated $119 million to resolve nearly 3,000 cases.

Cryoablation System OK’d in U.S., EU

Medtronic’s Arctic Front Advance ST cryoablation catheter has won FDA approval for the treatment of patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation. It also earned a CE mark for use in patients with atrial fibrillation, a wider indication than its American counterpart. The device is part of the Arctic Front Advance System, the only cryoballoon system to have the above indications in the U.S. and Europe. Medtronic plans a limited release followed by a wider launch this fall.